Suita, Japan

Kazuki Matsunaga

This inventor holds 2 USPTO granted patents. Top assignee: Shionogi Company Limited. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuki Matsunaga. Retrieved from https://idiyas.com/inventor/kazuki-matsunaga-ast0tjca

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kazuki Matsunaga: Innovator in Pharmaceutical Chemistry

Introduction

Kazuki Matsunaga is a notable inventor based in Suita, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address critical health issues.

Latest Patents

Matsunaga holds 2 patents related to Benzothiazepine derivatives. These compounds are characterized by a specific formula that includes various substituents, making them useful for treating hypertension and cardiac diseases. The pharmaceutical compositions derived from these compounds are designed to provide effective treatment options for patients suffering from these conditions.

Career Highlights

Kazuki Matsunaga is associated with Shionogi Company Limited, where he has been instrumental in advancing research and development in pharmaceutical innovations. His work has contributed to the creation of valuable therapeutic agents that enhance patient care.

Collaborations

Matsunaga has collaborated with esteemed colleagues such as Hiroshi Harada and Katsunori Sakai. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the pharmaceutical sector.

Conclusion

Kazuki Matsunaga's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to impact the treatment of hypertension and cardiac diseases, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…